Surmodics EBIT Margin 2010-2025 | SRDX
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Surmodics (SRDX) over the last 10 years. The current EBIT profit margin for Surmodics as of March 31, 2025 is .
| Surmodics EBIT Margin Historical Data |
| Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
| 2025-03-31 |
$0.12B |
$-0.01B |
-9.92% |
| 2024-12-31 |
$0.13B |
$-0.01B |
-5.60% |
| 2024-09-30 |
$0.13B |
$-0.01B |
-3.97% |
| 2024-06-30 |
$0.12B |
$-0.01B |
-4.96% |
| 2024-03-31 |
$0.14B |
$0.02B |
13.99% |
| 2023-12-31 |
$0.14B |
$0.01B |
8.70% |
| 2023-09-30 |
$0.13B |
$0.01B |
3.79% |
| 2023-06-30 |
$0.13B |
0 |
0.00% |
| 2023-03-31 |
$0.10B |
$-0.03B |
-27.18% |
| 2022-12-31 |
$0.10B |
$-0.03B |
-25.49% |
| 2022-09-30 |
$0.10B |
$-0.02B |
-22.00% |
| 2022-06-30 |
$0.10B |
$-0.02B |
-15.31% |
| 2022-03-31 |
$0.10B |
$-0.01B |
-10.31% |
| 2021-12-31 |
$0.11B |
$0.00B |
3.77% |
| 2021-09-30 |
$0.11B |
$0.01B |
6.67% |
| 2021-06-30 |
$0.10B |
$0.01B |
4.81% |
| 2021-03-31 |
$0.11B |
$0.01B |
7.48% |
| 2020-12-31 |
$0.10B |
$0.00B |
-1.05% |
| 2020-09-30 |
$0.10B |
$0.00B |
-1.04% |
| 2020-06-30 |
$0.10B |
$0.01B |
4.81% |
| 2020-03-31 |
$0.10B |
$0.01B |
4.95% |
| 2019-12-31 |
$0.10B |
$0.01B |
5.94% |
| 2019-09-30 |
$0.10B |
$0.01B |
7.00% |
| 2019-06-30 |
$0.09B |
$0.00B |
1.09% |
| 2019-03-31 |
$0.09B |
$-0.01B |
-6.67% |
| 2018-12-31 |
$0.09B |
$-0.01B |
-6.98% |
| 2018-09-30 |
$0.08B |
$-0.01B |
-9.88% |
| 2018-06-30 |
$0.08B |
$-0.01B |
-7.69% |
| 2018-03-31 |
$0.07B |
$0.00B |
2.70% |
| 2017-12-31 |
$0.07B |
$0.00B |
4.11% |
| 2017-09-30 |
$0.07B |
$0.01B |
9.46% |
| 2017-06-30 |
$0.07B |
$0.01B |
15.28% |
| 2017-03-31 |
$0.07B |
$0.02B |
21.62% |
| 2016-12-31 |
$0.07B |
$0.02B |
21.92% |
| 2016-09-30 |
$0.07B |
$0.02B |
23.61% |
| 2016-06-30 |
$0.07B |
$0.02B |
23.94% |
| 2016-03-31 |
$0.07B |
$0.02B |
23.88% |
| 2015-12-31 |
$0.06B |
$0.02B |
28.13% |
| 2015-09-30 |
$0.06B |
$0.02B |
31.15% |
| 2015-06-30 |
$0.06B |
$0.02B |
33.90% |
| 2015-03-31 |
$0.06B |
$0.02B |
32.76% |
| 2014-12-31 |
$0.06B |
$0.02B |
31.03% |
| 2014-09-30 |
$0.06B |
$0.02B |
29.31% |
| 2014-06-30 |
$0.06B |
$0.02B |
31.58% |
| 2014-03-31 |
$0.06B |
$0.02B |
30.36% |
| 2013-12-31 |
$0.06B |
$0.02B |
32.14% |
| 2013-09-30 |
$0.06B |
$0.02B |
33.93% |
| 2013-06-30 |
$0.06B |
$0.02B |
32.14% |
| 2013-03-31 |
$0.06B |
$0.02B |
33.93% |
| 2012-12-31 |
$0.05B |
$0.02B |
35.19% |
| 2012-09-30 |
$0.05B |
$0.02B |
32.69% |
| 2012-06-30 |
$0.05B |
$0.02B |
28.85% |
| 2012-03-31 |
$0.05B |
$0.01B |
27.45% |
| 2011-12-31 |
$0.05B |
$0.01B |
26.92% |
| 2011-09-30 |
$0.05B |
$0.02B |
28.30% |
| 2011-06-30 |
$0.06B |
$-0.01B |
-10.91% |
| 2011-03-31 |
$0.06B |
$-0.01B |
-13.11% |
| 2010-12-31 |
$0.07B |
$-0.01B |
-19.70% |
| 2010-09-30 |
$0.07B |
$-0.01B |
-20.00% |
| 2010-06-30 |
$0.07B |
$0.01B |
10.96% |
| 2010-03-31 |
$0.07B |
$0.01B |
15.28% |
| 2009-12-31 |
$0.08B |
$0.02B |
24.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.398B |
$0.126B |
|
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
|
